SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001571049-14-004800
Filing Date
2014-09-24
Accepted
2014-09-24 17:01:04
Documents
5
Period of Report
2014-11-10
Effectiveness Date
2014-09-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT t1401750-def14a.htm DEF 14A 1368247
2 GRAPHIC lg_phibro-alt.jpg GRAPHIC 32799
3 GRAPHIC sg_thomas-dagger.jpg GRAPHIC 19312
4 GRAPHIC t1401750_pc1.jpg GRAPHIC 706103
5 GRAPHIC t1401750_pc2.jpg GRAPHIC 1156386
  Complete submission text file 0001571049-14-004800.txt   4007977
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 141118840
SIC: 2834 Pharmaceutical Preparations